Transcription factor GATA-1 and Down syndrome leukemogenesis (Q28251869)

Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome

Europe PubMed Central

title

Transcription factor GATA-1 and Down syndrome leukemogenesis (English)

0 references

1 reference

John D Crispino

4

0 references

author name string

Andrew G Muntean

series ordinal

1

0 references

Yubin Ge

series ordinal

2

0 references

Jeffrey W Taub

series ordinal

3

0 references

language of work or name

English

0 references

publication date

June 2006

0 references

published in

Leukemia & Lymphoma

0 references

volume

47

0 references

issue

6

0 references

page(s)

986-97

0 references

cites work

1 reference

https://api.crossref.org/works/10.1080/10428190500485810

Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/10428190500485810

FOG, a multitype zinc finger protein, acts as a cofactor for transcription factor GATA-1 in erythroid and megakaryocytic differentiation

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/10428190500485810

Global regulation of erythroid gene expression by transcription factor GATA-1

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/10428190500485810

Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/10428190500485810

Rescue of erythroid development in gene targeted GATA-1- mouse embryonic stem cells

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/10428190500485810

Novel insights into erythroid development revealed through in vitro differentiation of GATA-1 embryonic stem cells

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/10428190500485810

Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/10428190500485810

Activation of the erythropoietin receptor promoter by transcription factor GATA-1

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/10428190500485810

Arrest in primitive erythroid cell development caused by promoter-specific disruption of the GATA-1 gene

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/10428190500485810

A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/10428190500485810

Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/10428190500485810

X-linked thrombocytopenia caused by a novel mutation of GATA-1

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/10428190500485810

Platelet characteristics in patients with X-linked macrothrombocytopenia because of a novel GATA1 mutation

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/10428190500485810

Different substitutions at residue D218 of the X-linked transcription factor GATA1 lead to altered clinical severity of macrothrombocytopenia and anemia and are associated with variable skewed X inactivation

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/10428190500485810

X-linked thrombocytopenia with thalassemia from a mutation in the amino finger of GATA-1 affecting DNA binding rather than FOG-1 interaction

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/10428190500485810

Alternative translation initiation site usage results in two functionally distinct forms of the GATA-1 transcription factor

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/10428190500485810

GATA1 in normal and malignant hematopoiesis

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/10428190500485810

The role of cytidine deaminase and GATA1 mutations in the increased cytosine arabinoside sensitivity of Down syndrome myeloblasts and leukemia cell lines

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/10428190500485810

Molecular cloning and chromosomal mapping of a bone marrow stromal cell surface gene, BST2, that may be involved in pre-B-cell growth

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/10428190500485810

Cloning of cDNA for the major DNA-binding protein of the erythroid lineage through expression in mammalian cells

21 April 2017

1 reference

https://api.crossref.org/works/10.1080%2F10428190500485810

FLT3: ITDoes matter in leukemia

21 April 2017

1 reference

https://api.crossref.org/works/10.1080%2F10428190500485810

On the molecular origins of the chronic myeloproliferative disorders: it all makes sense

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500485810

Extending the repertoire of the mixed-lineage leukemia gene MLL in leukemogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500485810

Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500485810

Acquired mutations in GATA1 in neonates with Down's syndrome with transient myeloid disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500485810

GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500485810

Frequent mutations in the GATA-1 gene in the transient myeloproliferative disorder of Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500485810

Natural history of GATA1 mutations in Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500485810

The erythroid-specific transcription factor Eryf1: a new finger protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500485810

Transcriptional activation and DNA binding by the erythroid factor GF-1/NF-E1/Eryf 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500485810

The N-terminal zinc finger of the erythroid transcription factor GATA-1 binds GATC motifs in DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500485810

GATA-1-mediated proliferation arrest during erythroid maturation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500485810

Repression of c-kit and its downstream substrates by GATA-1 inhibits cell proliferation during erythroid maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500485810

A "knockdown" mutation created by cis-element gene targeting reveals the dependence of erythroid cell maturation on the level of transcription factor GATA-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500485810

Graded levels of GATA-1 expression modulate survival, proliferation, and differentiation of erythroid progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500485810

Leukemogenesis caused by incapacitated GATA-1 function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500485810

Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500485810

PU.1 is a suppressor of myeloid leukemia, inactivated in mice by gene deletion and mutation of its DNA binding domain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500485810

Effect of transcription-factor concentrations on leukemic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500485810

Differential requirements for the activation domain and FOG-interaction surface of GATA-1 in megakaryocyte gene expression and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500485810

Early block to erythromegakaryocytic development conferred by loss of transcription factor GATA-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500485810

Dyserythropoietic anemia and thrombocytopenia due to a novel mutation in GATA-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500485810

Leukemia in Down syndrome: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500485810

Transient leukaemia--a benign form of leukaemia in newborn infants with trisomy 21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500485810

Transient myeloproliferative disorder, a disorder with too few data and many unanswered questions: does it contain an important piece of the puzzle to understanding hematopoiesis and acute myelogenous leukemia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500485810

The management of neoplastic disorders of haematopoiesis in children with Down's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500485810

Distinct roles for the two cGATA-1 finger domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500485810

The C-terminal zinc finger of GATA-1 or GATA-2 is sufficient to induce megakaryocytic differentiation of an early myeloid cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500485810

Rescue of GATA-1-deficient embryonic stem cells by heterologous GATA-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500485810

Erythroid-cell-specific properties of transcription factor GATA-1 revealed by phenotypic rescue of a gene-targeted cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500485810

In vivo requirements for GATA-1 functional domains during primitive and definitive erythropoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500485810

Origins of leukaemia in children with Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500485810

GATA1-mediated megakaryocyte differentiation and growth control can be uncoupled and mapped to different domains in GATA1

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500485810

GATA-1-dependent transcriptional repression of GATA-2 via disruption of positive autoregulation and domain-wide chromatin remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500485810

Context-dependent regulation of GATA-1 by friend of GATA-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500485810

Coregulator-dependent facilitation of chromatin occupancy by GATA-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500485810

Overexpression of GATA-2 inhibits erythroid and promotes megakaryocyte differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500485810

AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500485810

Myelodysplasia and acute megakaryoblastic leukemia in Down's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500485810

Increased age at diagnosis has a significantly negative effect on outcome in children with Down syndrome and acute myeloid leukemia: a report from the Children's Cancer Group Study 2891.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500485810

An effective chemotherapeutic regimen for acute myeloid leukemia and myelodysplastic syndrome in children with Down's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500485810

Down syndrome, drug metabolism and chromosome 21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500485810

GATA1, cytidine deaminase, and the high cure rate of Down syndrome children with acute megakaryocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500485810

Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500485810

Transcriptional regulation of the cystathionine-beta -synthase gene in Down syndrome and non-Down syndrome megakaryocytic leukemia cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500485810

Nucleoside analogues: mechanisms of drug resistance and reversal strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500485810

Molecular cloning and characterization of a surface antigen preferentially overexpressed on multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500485810

10.1080/10428190500485810

21 January 2018

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

16840187

1 reference

Consolidated OpenCitations Corpus – April 2017